Answers are grounded in this paper and cite their sources.
Clinical review outlines the mechanisms and management of acute graft-versus-host disease in transplant recipients, highlighting the necessity of prompt immunosuppressive therapy.
When T cells from a bone marrow donor begin to attack the host within 3 months after hematopoietic-cell transplantation, acute graft-versus-host disease results. The disease mainly affects the skin, liver, and gastrointestinal tract and is treated with immunosuppressive drugs.
No takes yet. Share an insight, caveat, or question.
Zeiser et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: